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Abstract
Background and Purpose: The presence of good collaterals on CT angiography (CTA) is a well-known predictor for
favorable outcome in acute ischemic stroke. Recently, multiphase CT has been introduced as a more accurate method in
assessing collaterals. The aim of this study was to assess the ability of dual-phase CT to evaluate collateral status and predict
clinical outcome.
Methods: Forty-three patients who underwent both dual-phase CT and transfemoral cerebral angiography (TFCA) for
occluded intracranial internal carotid artery (ICA) and/or middle cerebral artery (M1 segment) were recruited from a
prospectively collected database. The collateral status on dual-phase CT was graded by using a 4-point scale: grade 0 = no
collaterals; 1 = some collaterals with persistence of some defects; 2 = slow but complete collaterals; and 3 = fast and
complete collaterals. Univariate and multivariate analysis were performed to define the independent predictors for
favorable outcome at 3 months.
Results: Dual-phase CT collateral status (r= 0.744) showed higher correlation with TFCA collateral status than CTA collateral
status (r= 0.596) and substantial interobserver agreement (weighted k= 0.776). In the univariate analysis, age, history of
hypertension, collateral scores on CTA, dual-phase CT, and TFCA, occlusion in intracranial ICA, final infarct volume, and
symptomatic hemorrhage were significantly associated with outcome. Among them, only the dual-phase CT collateral score
was an independent predictor for favorable outcome (OR= 26.342 (2.788–248.864); P= 0.004) in the multivariate analysis.
Conclusions: The collateral status on dual-phase CT can be a useful predictor for clinical outcome in acute stroke patients,
especially when advanced CT techniques are not available in emergent situations.
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Introduction
The presence of good collateral circulation to the ischemic
territory is a notable predictor for favorable long term clinical
outcome as well as small infarct size and good response to
treatment in patients with proximal intracranial arterial occlusion
[1–6]. These beneficial roles may be attributable to preserve
downstream perfusion distal to occluded vessels, to permit access
of thrombolytic materials to the distal end of the clot by retrograde
flow, and to augment washout of emboli in distal arteries [7–9].
Transfemoral cerebral angiography (TFCA) has been consid-
ered as a gold standard to assess collateral status owing to its
temporal and spatial resolution. However, global evaluation of pial
collateral flow requires catheterization of multiple vessels and, as
an invasive investigation with recognized complication rate, is
usually only performed when IA treatment is indicated. To aid
selection of treatment strategy or to prognosticate, a method of
collateral assessment for all stroke patients, not just for those
undergoing intra-arterial therapy is warranted. Furthermore,
accurate non-invasive assessment of collateral status prior to
endovascular therapy would also be advantageous. Therefore,
noninvasive assessment of collateral status before IA treatment or
in patients who are not candidates for IA treatment may be helpful
to select the treatment strategy and predict long term outcome.
Because of short scan times and easy accessibility, computed
tomography (CT) is used as the first imaging modality in most
patients with acute ischemic stroke. Diverse collateral scoring
methods have been suggested in the last decades using CT
angiography source images (CTA-SI) [4,5,7,10–14] and CTA
maximum intensity projection (MIP) images [6,12,15,16]. Al-
though there is no standard scoring system, CTA allows prediction
of clinical outcome with moderate to excellent interobserver
agreement [11–13,16,17]. To overcome limitations of CTA such
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as absence of temporal information from single phase acquisition
and possible underestimation of collateral status from faster image
acquisition, multi- [18,19] or tri-phase CT [20] and perfusion CT
[3,21] have been proposed for assessing collateral status. At our
institution, the routine CT protocol consists of noncontrast CT
(NCCT), CTA, and delayed contrast enhanced CT (CECT). We
empirically found that dual-phase CT composed of CTA and
delayed CECT is helpful for predicting clinical outcome in
patients with acute stroke. Therefore, the aim of this study was to
assess the ability of dual-phase CT to evaluate collateral status and
predict clinical outcome.
Materials and Methods
Patients
The patients were retrospectively selected from a prospectively
collected neurointerventional database in a single institution. From
February 2011 to June 2013, we recruited consecutive patients
who underwent TFCA for possible thrombolysis/mechanical
thrombectomy for acute ischemic stroke and met the following
inclusion criteria: (1) occlusion of the intracranial ICA or M1
segment; (2) time from symptom onset to admission,6 hours; and
(3) presence of a standard local CT protocol including NCCT,
CTA, and delayed CECT. Exclusion criteria included bilateral
anterior circulation occlusion, posterior circulation occlusion,
significant stenosis in contralateral anterior circulation, and past
history of stroke.
Clinical data were collected from a prospectively recorded
stroke registry database. Type of stroke etiology was classified
using Trial of Org 10172 in Acute Stroke Treatment (TOAST)
criteria [22]. Functional outcome was assessed using the modified
Rankin Scale score (mRS) at 3 months and classified as favorable
(#2) and unfavorable (.2). This study was approved by Severance
hospital Institutional Review Board. The Clinical Research Ethics
Committee waived the need for written informed consent from the
participants because the data released from the hospital database
were analyzed anonymously.
Image Acquisition
CT images were obtained on a 64 multi-detector row CT
system (Sensation 64; Siemens, Erlangen, Germany). The sequen-
tial axial 3-mm NCCT was performed first with the following
parameters from the skull base to the vertex: 120 kVp, 300 mAs,
field of view (FOV) of 25 cm, feed/rotation 18 mm, 3060.6 mm
collimation and a H30s medium reconstruction kernel. Each of the
conventional axial CT images was subsequently reconstructed into
1.2 mm slices and 1.2 mm increments. A nonionic contrast agent
was administered followed by a 40 ml saline chaser at a rate of
4 ml/s by using a power injector. A bolus tracking technique was
used with a marker placed at the ascending aorta, triggering at 100
Hounsfield Units (HU) above baseline with a 7 s delay prior to
image acquisition. CTA from the aortic arch to the vertex was
performed with the following parameters: 120 kVp, 160 mA,
FOV of 18–20 cm, 0.33 s per rotation, 0.8 pitch, and a 0.6-mm
section thickness. Delayed CECT was performed with the same
parameters as NCCT 40 s after contrast injection. The effective
dose which was calculated by the CTDI volume x the scan range x
the conversion factor was 1.8 mSv for NCCT and CECT,
respectively, 0.9 mSv for the cranial portion of CTA, and
3.0 mSv for the cervical portion of CTA. Therefore the total
effective dose was 5.7mSv.
TFCA was performed using biplane digital subtraction angio-
grams (Allura Xper FD20/20; Philips Healthcare, Best, Nether-
lands) in all patients for the purpose of IA thrombolysis/
thrombectomy via bilateral ICAs and the dominant vertebral
artery.
Routine follow-up MRI was obtained 1 day after the onset of
symptoms with the 3-Tesla MR system (Achieva; Philips
Healthcare, Best, Netherlands). DWI was performed with single
shot echo planar imaging and parameters were as follows: b-value
1000 s/mm2, TR/TE 6500–7000/65–78 ms, slice thickness
3 mm, FOV 230 mm, matrix 1286128, and NEX 1.
Image Analysis
Imaging studies at admission. CT: The extent of ischemic
lesions on NCCT scan images at admission was rated according to
the Alberta Stroke Programme Early CT Score (ASPECTS) [23].
Collaterals on dual-phase CT were graded on CTA and delayed
CECT axial MIP images by using a 4-point scale [19]: Grade
0=no collaterals to the occluded arterial territory; 1 = some
collaterals to the occluded arterial territory with persistence of
Figure 1. Representative images of collateral status on dual-
phase CT. A, Some collaterals to the right MCA territory on CTA with
persistence of some defects on CECT (Grade 1). B, Collaterals in part of
the left MCA territory on CTA with complete filling on CECT (Grade 2).
The collaterals show lower attenuation on CTA with equal to higher
attenuation on CECT than unaffected vessels, suggesting slow inflow
and washout of collaterals. C, Collaterals in the entire right MCA
territory on both CTA and delayed CECT (Grade 3). The collateral vessels
show attenuation similar to unaffected vessels on both phase images,
suggesting fast velocity of collaterals.
doi:10.1371/journal.pone.0107379.g001
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Table 1. Demographic characteristics according to dual-phase collateral status.
Collateral status on dual-phase CT
Incomplete (G1)
(n =10)
Slow-complete
(G2) (n =23)
Rapid-complete (G3)
(n=10) P value Post-hoc analysis
Age, y, mean 6 SD 75.966.8 70.1610.7 61.1611.4 0.010* G1.G3 (P= 0.008)
Sex, n, M:F 4:3 13:10 6:4 0.974`
Risk factors
Hypertension, n (%) 9 (90.0) 14 (60.9) 1 (10.0) 0.001` G1.G3 (P= 0.002)
Diabetes, n (%) 4 (40.0) 5 (21.7) 0 (0.0) 0.109`
Hypercholesterolemia,
n (%)
3 (30.0) 2 (8.7) 0 (0.0) 0.147`
Smoking, n (%) 6 (60.0) 8 (34.8) 6 (60.0) 0.302`
Coronary artery disease,
n (%)
3 (30.0) 10 (43.5) 3 (30.0) 0.763`
Clinical measures at
presentation
SBP, mmHg, median (IQR) 134.0 (111.0–161.0) 135.0 (120.0–146.5) 138.5 (112.0–149.0) 0.947{
DBP, mmHg, mean 6 SD 78.5 mmHg 76.3 mmHg 74.9 mmHg 0.680*
Glucose, mmol/L, median
(IQR)
7.25 (6.9–8.6) 6.7 (5.7–8.3) 7.1 (5.9–8.9) 0.490{
NIHSS score, median (IQR) 16.5 (12.0–19.0) 17.0 (14.3–19.0) 14.0 (13.0–19.0) 0.210{
TOAST classification 0.015`
Large artery, n (%) 1 (10.0) 2 (8.7) 6 (60.0)
Cardioembolic, n (%) 7 (70.0) 14 (60.9) 4 (40.0)
Undetermined, n (%) 2 (20.0) 7 (30.4) 0 (0.0)
CT
Time from symptom onset
to CT, min, mean 6 SD
170.96106.6 209.0691.1 170.0687.1 0.415*
ASPECTS, mean 6 SD 6.361.8 7.661.2 8.561.0 0.002* G1,G2 (P= 0.038), G1,G3 (P=0.002)
Occluded segment
Intracranial ICA, n (%) 5 (50.0) 4 (17.4) 0 (0.0) 0.018`
Proximal M1, n (%) 7 (70.0) 16 (69.6) 7 (70.0) 1.000`
Distal M1, n (%) 8 (80.0) 20 (87.0) 8 (80.0) 0.753`
Thrombus length, mm,
median (IQR)
19.3 (11.9–25.5) 15.8 (8.6–18.5) 11.0 (7.3–18.8) 0.298{
IV tPA
IV tPA, n (%) 5 (50.0) 11 (47.8) 8 (80.0) 0.275.
Time from symptom onset
to IV tPA, min, mean 6 SD
77.8620.6 108.6641.4 91.4638.2 0.301*
TFCA
TICI $ 2b, n (%) 5 (50.0) 5 (21.7) 2 (20.0) 0.264
Time from symptom onset
to recanalization
385.36198.2 375.36106.3 304.06103.0 0.447
Outcome
Final infarct volume, ml,
median (IQR)
91.1 (49.1–183.2) 25.0 (10.3–76.7) 12.3 (7.5–27.8) 0.047 G1.G2 (P= 0.012), G1.G3 (P=0.021)
Symptomatic hemorrhage 3 (30.0) 3 (13.0) 1 (10.0) 0.537
parenchymal hematoma 5 (50.0) 4 (17.4) 2 (20.0) 0.199
3m-mRS # 2 0 (0.0) 14 (60.9) 9 (90.0) ,0.001 G1,G2 (P= 0.003), G1,G3 (P,0.001)
ASPECTS indicates Alberta Stroke Program Early CT Score; DBP, diastolic blood pressure; IQR, Interquatile range; mRS, modified Rankin Score; NIHSS, National Institutes
of Health Stroke Scale; SBP indicates systolic blood pressure; TICI, thrombolysis in cerebral infarction; TOAST, Trial of Org 10172 in Acute Stroke Treatment; and tPA,
tissue plasminogen activator.
* one-way ANOVA; { Kruskal Wallis test; ` Fisher’s exact test
doi:10.1371/journal.pone.0107379.t001
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some defects; 2 = slow but complete collaterals (detectable only on
delayed CECT) without defects; and 3= fast and complete
collaterals (detectable on both CTA and delayed CECT;
Figure 1). Collateral vessel scores were assessed on CTA-SI
images using a scale of 0–3: 0 = absence of collateral supply to
the occluded vascular territory; 1 = collateral supply filling ,50%
but .0% of the occluded vascular territory; 2 = collateral supply
filling .50% but ,100% of the occluded vascular territory; and
3= collateral supply filling 100% of the occluded vascular territory
[6]. The collateral scores on both dual-phase CT and CTA were
evaluated independently by two neuroradiologist (N.Y.S. with 4
years of experience and M.P. with 1 year of experience) blinded to
the clinical data. Disagreements were settled by consensus.
Occluded segments were recorded based on the location of the
non-enhanced segment on delayed CECT as follows [24]:
intracranial ICA; proximal M1 segment = occlusion at or proximal
to the lenticulostriate arteries; and distal M1 segment = occlusion
distal to the lenticulostriate arteries before MCA genu. The
thrombus length was measured quantitatively on CECT curved
multiplanar reformatted (MPR) images by a neuroimaging fellow
(K.E.K. with 1 year of experience) blinded to the clinical data.
TFCA: The collateral flow grading system suggested by the
Technology Assessment Committees of the American Society of
Interventional and Therapeutic Neuroradiology and the Society of
Interventional Radiology [24] was used to assess collateral vessels
on TFCA: grade 0=no collaterals to the ischemic region; 1= slow
collaterals to the periphery of the ischemic region with persistence
of some defects; 2 = rapid collaterals to the periphery of the
ischemic region with persistence of some defects; 3 = slow but
complete collaterals to the ischemic bed by the late venous phase;
and 4= complete and rapid collaterals. The assessment of
collateral flow was performed through arterial and late venous
phases considering all possible collaterals from bilateral carotid
and dominant vertebral angiography.
TICI score was recorded to assess recanalization using a 5-point
scale [24]: 0 = no perfusion; 1= penetration of contrast material
beyond the occluded segment with minimal perfusion; 2a= partial
perfusion (,2/3) of the entire vascular territory; 2b= complete but
slow perfusion of the entire vascular territory; and 3= complete
perfusion and rapid clearance comparable to the uninvolved
vascular territory. TICI 2b and 3 were considered recanalization.
Imaging outcome. The final infarct volume was measured
on diffusion weighted images of 1-day follow-up MRI [25] using
semiautomatic segmentation. The hemorrhagic transformation on
follow-up CT or MRI was classified into hemorrhagic infarction or
parenchymal hematoma and determined if it was symptomatic
hemorrhage according to ECASS criteria [26].
Statistics
Nonparametric tests were used for non-normally distributed
data. Baseline characteristics were compared according to
collateral status on dual-phase CT. Continuous variables are
reported as mean 6 SD or as the median (interquartile range
(IQR)) and were compared using one-way analysis of variance or
the Kruskal-Wallis test. Categorical variables are reported as
numbers (proportions, %) and were compared using the Fisher’s
exact test. Post hoc analysis was also performed using the Students’
t-test, Mann-Whitney U test, chi-square test, or Fisher’s exact test
where appropriate with correction for multiple comparisons.
Spearman’s rank correlation was used to assess the correlation
between collateral status on dual-phase CT or CTA and collateral
status on TFCA. Interobserver agreement for assessment of
collateral status on CT was determined using weighted Kappa (k)
statistics [27]. The level of agreement was defined as follows: k#
0.2, poor; 0.2,k#0.4, fair; 0.4,k#0.6, moderate; 0.6,k#0.8,
substantial, and 0.8,k, good.
To test the association between various clinical and imaging
characteristics including collateral status on dual-phase CT and
clinical outcome, univariate logistic regression was performed.
Figure 2. Clinical outcome according to collateral status. All patients with incomplete collaterals showed unfavorable outcome at 3 months.
Patients with complete collaterals had favorable clinical outcome more frequently than did patients with incomplete collaterals. * P= 0.003; ** P,
0.001
doi:10.1371/journal.pone.0107379.g002
Dual-Phase CT Collateral Score
PLOS ONE | www.plosone.org 4 September 2014 | Volume 9 | Issue 9 | e107379
Table 2. Univariate analysis for favorable clinical outcome (mRS #2) at 3 months.
Favorable (n=23) Unfavorable (n =20) Univariate analysis
Odds ratio 95% CI P value
Age, y, mean 6 SD 66.1610.2 73.4611.0 0.934 0.874–0.997 0.040
Male, n (%) 16 (69.6) 9 (45.0) 2.794 0.800–9.760 0.107
Risk factors
Hypertension, n (%) 9 (39.1) 15 (75.0) 0.214 0.058–0.797 0.022
Diabetes, n (%) 4 (17.4) 5 (25.0) 0.632 0.144–2.771 0.542
Hypercholesterolemia, n (%) 1 (4.3) 4 (20.0) 0.182 0.019–1.785 0.143
Smoking, n (%) 12 (52.2) 8 (40.0) 1.636 0.487–5.500 0.426
Coronary artery disease, n (%) 11 (47.8) 5 (25.0) 2.749 0.748–10.102 0.128
Clinical measures at admission
SBP, mmHg, median (IQR) 135.0 (114.0–144.0) 140.5 (113.5–163.5) 0.980 0.956–1.005 0.114
DBP, mmHg, mean 6 SD 73.5611.0 79.9617.3 0.967 0.924–1.013 0.157
Glucose, mmol/L, median (IQR) 6.7 (103.0–154.3) 7.25 (121.0–152.5) 1.028 0.793–1.334 0.833
NIHSS score, median (IQR) 15.0 (13.0–16.8) 18.0 (15.5–19.0) 0.873 0.747–1.020 0.088
Delays
Time from symptom onset to IV tPA,
min, mean 6 SD
96.8639.5 96.4636.7 1.000 0.978–1.023 0.983
Time from symptom onset to CT, min,
mean 6 SD
198.0695.7 183.0693.2 1.002 0.995–1.008 0.596
Time from symptom onset to IA
treatment, min, mean 6 SD
268.26107.9 259.26113.8 1.001 0.995–1.006 0.785
TOAST classification
Large artery, n (%) 7 (30.4) 2 (10.0) Reference 0.286
Cardioembolic, n (%) 12 (52.2) 13 (65.0) 0.264 0.046–1.528 0.137
Undetermined, n (%) 4 (17.4) 5 (25.0) 0.229 0.029–1.774 0.158
CT
ASPECTS, mean 6 SD 8.060.9 6.961.8 1.908 1.135–3.209 0.015
CTA Collateral score 2.0 (2.0–3.0) 1.0 (1.0–2.0) 6.077 1.926–19.167 0.002
0, n (%) 0 (0.0) 0 (0.0)
1, n (%) 4 (17.4) 14 (70.0)
2, n (%) 12 (52.2) 5 (25.0)
3, n (%) 7 (30.4) 1 (5.0)
Dual-phase CT collateral score 2.460.5 1.660.6 19.436 2.581–146.371 0.004
0, n (%) 0 (0.0) 0 (0.0)
1, n (%) 0 (0.0) 10 (50.0)
2, n (%) 14 (60.9) 9 (45.0)
3, n (%) 9 (39.1) 1 (5.0)
Occluded segment
Intracranial ICA, n (%) 2 (8.7) 7 (35.0) 0.177 0.032–0.985 0.048
Proximal M1, n (%) 14 (60.9) 16 (80.0) 0.389 0.098–1.544 0.179
Distal M1, n (%) 20 (87.0) 16 (80.0) 1.667 0.325–8.549 0.540
Thrombus length, mm, median (IQR) 11.4 (7.4–17.6) 17.9 (10.4–22.8) 0.938 0.871–1.011 0.093
Treatment
IV tPA only, n (%) 3 (13.0) 0 (0.0) Reference 0.639
IA only, n (%) 8 (34.8) 11 (55.0) 0.000 0.000 0.999
IV tPA and IA, n (%) 12 (52.2) 9 (45.0) 0.000 0.000 0.999
TFCA
TFCA collateral score 3.0 (2.3–4.0) 2.0 (1.0–2.0) 3.092 1.537–6.221 0.002
0, n (%) 0 (0.0) 0 (0.0)
1, n (%) 2 (8.7) 8 (40.0)
Dual-Phase CT Collateral Score
PLOS ONE | www.plosone.org 5 September 2014 | Volume 9 | Issue 9 | e107379
Multivariate logistic regression with backward elimination (prob-
ability value for elimination of 0.1) was used to identify
independent factors for favorable outcome. Variables significantly
associated with a favorable outcome in the univariate analysis (P,
0.05) were included in the multivariable model. To assess
independent predictors before IA treatment, multivariate analysis
with clinical and CT variables was also performed. Receiver
operating curve (ROC) comparison was performed to compare the
prediction ability of models containing either dual-phase CT
collateral (model 1), CTA collateral (model 2), or TFCA collateral
(model 3) scores.
All statistical analyses were performed using SAS, version 9.2
(SAS Institute, Cary, NC, USA) and SPSS, version 19 software
(IBM Corp., Armonk, NY, USA). ROC curve comparison was
performed by using MedCalc, Version 9.3.9.0 software (MedCalc
software, Mariakerke, Belgium). P values less than 0.05 were
considered statistically significant.
Results
Among 166 patients who underwent TFCA for possible
thrombolysis/mechanical thrombectomy for acute ischemic
stroke, 123 patients were excluded due to posterior circulation
occlusion (n= 34), anterior cerebral arterial occlusion (n = 4),
occlusion distal to the M1 segment (n = 41), proximal ICA
occlusion only (n = 12), old territorial infarcts (n = 8), multiple
territorial infarcts due to cardioembolism (n = 2), significant
stenosis in the contralateral M1 segment (n = 1), moyamoya
disease (n = 1), and only NCCT acquisition (n= 20). Therefore, a
total of 43 patients were recruited for this study. The patients
underwent IA treatment with stent-assisted thrombectomy (SAT;
n= 29), Penumbra system (n= 1), both SAT and Penumbra system
(n = 4), stent placement after mechanical thrombectomy (n = 4),
Penumbra system with urokinase infusion (n= 2), and urokinase
infusion only (n = 1).
Patient demographic and clinical data according to collateral
status on dual-phase CT are summarized in Table 1. Ten (23.3%)
patients were grouped as grade 1 (incomplete collaterals); 23
(53.5%) as grade 2 (slow-complete collaterals); and 10 (23.3%) as
grade 3 (rapid-complete collaterals). No patients were classified as
grade 0 (no collaterals). There was no statistical difference in the
time from symptom onset to CT scan between there groups
(P=0.415). Patients with incomplete collaterals were older than
those with rapid-complete collaterals (P=0.008). Patients with less
collaterals had hypertension more often, although other cardio-
vascular risk factors did not show differences in the prevalence
across different collateral patterns. The pattern of leptomeningeal
collaterals on dual-phase CT was also associated with the TOAST
classification of stroke: cardioembolic infarcts were observed more
often in patients with less collaterals than those with large arterial
infarcts. Less collaterals were associated with lower ASPECTS on
NCCT (P=0.002) and the presence of intracranial ICA occlusion
(P=0.018). Final infarct volume was significantly larger in patients
with incomplete collaterals (91.1 (IQR, 49.1–183.2) ml) than that
in patients with slow-complete (25.0 (IQR, 10.3–76.7) ml) and
rapid-complete (12.3 (IQR, 7.5–27.8) ml) collaterals on dual-phase
CT (P= 0.012 and P= 0.021, respectively). Clinical outcome was
also more favorable in patients with complete collateral patterns
(Figure 2). However, there was no significant difference in
recanalization rate or hemorrhagic transformation according to
collateral pattern.
The dual-phase collateral scores showed higher correlation with
collateral status on TFCA (r=0.744; P,0.001) than that of the
CTA collateral scores (r=0.596; P,0.001). Interobserver agree-
ment for the collateral scoring on dual-phase CT [weighted
k=0.776 (0.619–0.933)] was substantial and better than that on
CTA [weighted k=0.475 (0.285–0.665)].
Univariate analysis of patients with good and poor clinical
outcome is presented in Table 2. Younger age (P=0.040),
absence of history of hypertension (P=0.022), higher collateral
scores on CTA (P=0.002), dual-phase CT (P=0.004), and TFCA
(P=0.002), absence of occlusion in intracranial ICA (P=0.048),
smaller final infarct volume (P=0.003), and absence of symptom-
atic hemorrhage (P=0.048) were all significantly associated with
favorable clinical outcome. Multivariate analysis of all significant
variables using backward elimination showed that only the
collateral score on dual-phase CT [odds ratio (OR) = 26.342
(2.788–248.864); P=0.004] was an independent predictor for
favorable outcome with adjustment for NIHSS scores at admission
[OR=0.834 (0.679–1.025); P=0.085]. Moreover, multivariate
analysis with significant clinical and imaging variables before IA
treatment also showed the dual-phase CT collateral score
[OR=27.117 (1.519–484.258); P=0.025] as an independent
Table 2. Cont.
Favorable (n=23) Unfavorable (n =20) Univariate analysis
Odds ratio 95% CI P value
2, n (%) 4 (17.4) 8 (40.0)
3, n (%) 6 (26.1) 2 (10.0)
4, n (%) 11 (47.8) 2 (10.0)
TICI $ 2b, n (%) 4 (17.4) 8 (40.0) 0.316 0.078–1.282 0.107
Time from symptom onset to
recanalization, min, mean 6 SD
352.06110.6 383.06152.3 0.998 0.993–1.003 0.998
Imaging outcome
Final infarct volume, ml, median (IQR) 13.7 (7.2–25.0) 80.7 (34.0–144.8) 0.965 0.943–0.988 0.003
Symptomatic hemorrhage, n (%) 1 (4.3) 6 (30.0) 0.106 0.012–0.977 0.048
Parenchymal hematoma, n (%) 3 (13.0) 8 (40.0) 0.225 0.050–1.016 0.052
ASPECTS indicates Alberta Stroke Program Early CT Score; DBP, diastolic blood pressure; IQR, Interquatile range; mRS, modified Rankin Score; NIHSS, National Institutes
of Health Stroke Scale; SBP indicates systolic blood pressure; TFCA, transfemoral cerebral angiography; TICI, thrombolysis in cerebral infarction; TOAST, Trial of Org
10172 in Acute Stroke Treatment; and tPA, tissue plasminogen activator.
doi:10.1371/journal.pone.0107379.t002
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predictor for clinical outcome even after adjustment of age,
presence of hypertension, NIHSS score at admission, ASPECTS,
and occlusion of intracranial ICA. Meanwhile, the CTA collateral
score in model 2 was not an independent predictor (P=0.062)
unlike dual-phase CT collateral score in model 1. Although the
TFCA collateral score was also an independent predictor
[OR=2.996 (1.138–7.890); P=0.026], the area under the curve
(AUC) of model 3 (0.874) was lower than that of model 1 (0.922).
However, it failed to achieve a level of statistical significance
(P=0.206; Table 3).
Discussion
The present study suggests collateral status on dual-phase CT
may be an independent predictor [OR=26.342 (2.788–248.864);
P=0.004] for clinical outcome in acute ischemic stroke patients
who are subjected to IA treatment. Moreover, after adjustment of
clinical and CT variables measured before IA treatment, collateral
status on dual-phase CT was also an independent predictor for
clinical outcome [OR=25.763 (1.342–494.601); P=0.031]. On
the other hand, the CTA collateral score could not independently
predict clinical outcome in model 2. Also, although there was no
statistical significance, the prediction model with the dual-phase
CT collateral score was better than that with TFCA collateral
scores.
Leptomeningeal collaterals have been considered as having a
beneficial role in patients with acute stroke despite various scoring
scales and different imaging modalities [17]. CT, which is
noninvasive and widely available in emergency situations, has
been used to evaluate collateral status. Above all, CTA-based
methods are the most commonly suggested so far [4–6,10–14].
However, the prediction power of these methods can be influenced
by small differences in time delay from contrast injection to image
acquisition as there is no dynamic information on single phase
CTA. Before the era of fast CTA acquisition, CTA images were
acquired under an almost steady-state condition with maximal
enhancement in arteries and tissues. Therefore, the nonenhanced
area on this protocol is associated with decreased cerebral blood
volume and can be a predictor for cerebral infarction [11]. After
the introduction of multidetector CT that has made fast
acquisition of CTA possible, slowly perfused areas via collaterals
might not be enhanced on CTA images causing overestimation of
infarct core [28] and thrombus length [29] as well as underesti-
mation of collateral status [21,30]. To overcome limitations of
single phase CTA, multi- [18,19] and tri-phase [20,31] CT and
perfusion CT [3,21] have been suggested as a tool to assess
collateral status; but the additional value of these advanced
techniques over single phase CTA to predict clinical outcome lacks
confirmation. Moreover, lack of ubiquitousness of these advanced
sequences and post processing techniques, insufficient scan
coverage, and potential radiation hazard caused by additional
CT scans might be problems in daily clinical practice.
A previous study using tri-phase CT [31] graded collateral
scores on each phase image and focused on identifying the best
phase to predict infarct volume. A recent study with time-resolved
assessment of collateral status on perfusion CT [21] also scored
collateral status on early and peak phases and temporal MIP
reconstruction images which were obtained by fusing contrast
enhancement across the whole duration of the 4-dimensional
CTA. This study classified patients into incomplete, slow-
complete, and rapid-complete collateral flow groups by integrating
dynamic information from various phase images. In addition, they
also showed that complete collateral flow groups achieve favorable
clinical outcome more often; however, the effective dose of this CT
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protocol was 8.5 mSv excluding NCCT. Kim et al. [19] obtained
multiphase CT and evaluated collateral status on mid (23 and 32 s
after contrast injection) and late (41 and 50 s after contrast
injection) phase CECT images by using the same scales that were
used in our study. They found high correlation between collateral
status on these two phase images and TFCA. However, analysis of
the effect of collateral status on multiphase CT on clinical outcome
was not conducted. It is worth noting that the time delay between
contrast injection and image acquisition of mid and late phases
were similar to those of CTA and delayed CECT in the present
study. Thus, supporting that only dual-phase CT with optimized
time delay from contrast injection may have sufficient dynamic
information to show collateral status.
In this study, collateral scores on dual-phase CT showed better
correlation with collateral status on TFCA and higher interob-
server agreement than did collateral scores on single phase CTA.
Also, as mentioned above, collateral status on dual-phase CT was
an independent predictor for clinical outcome; however, collateral
scores on single phase CTA and even TFCA were not. On dual-
phase CT, detection of collateral defects on CTA and delayed
CECT was needed. On the other hand, additional detection on
the degree (smaller or larger than 50% of the occluded territory) of
collateral extent was required on single phase CTA. Therefore, the
observers might grade collateral status more consistently on dual-
phase CT. Both dual-phase CTA and TFCA provide dynamic
information of collaterals; however, it is difficult to evaluate pial
collaterals from whole cerebral circulation by TFCA, so the
prediction power for clinical outcome might be lower than that of
dual-phase CT.
Among the patients with complete collaterals on dual-phase
CT, patients with rapid-complete collaterals had higher ASPECT
scores at admission (7.6 vs. 8.5), smaller final infarct volume
(25.0 ml vs. 12.3 ml), and more frequent favorable clinical
outcome (60.9% vs. 90%) than patients with slow-complete
collaterals. Although there was no significant differences between
the two groups as reported in a previous study [21], the number of
patients may have been too small to reach a statistically significant
conclusion. Therefore, prospective studies with larger sample size
and an optimized CT protocol are warranted to establish the
influence of collateral velocity on clinical outcome.
There were several limitations in our study. First, this study was
a retrospective study although the patients were recruited from a
prospectively collected database. Also a small number of patients
included in the analysis might cause a wide range of 95% CI of
OR of dual-phase CT collateral status and its overestimation.
Therefore, caution is needed in generalizing the results of this
study. Second, more than 50% of patients were treated with IV
thrombolysis. As a result of the IV treatment, potential confound-
ing factors may have influenced the assessment of collateral status
on TFCA and prediction of clinical outcome. There might be
difference in thrombus extent and the collateral status between CT
and TFCA. Third, there is the possibility that selection bias may
exist. Patients who achieved recanalization only after IV treatment
or had substantial ischemic change larger than 1/3 of the middle
cerebral artery (MCA) territory were not subjected to IA treatment
and excluded from this study. We also excluded considerable
number of patients according to the exclusion criteria. However,
our results could be applied to a relatively homogenous patient
group with occlusion of distal ICA or M1 segments who are
indicated for IA treatment. Fourth, we did not perform multiphase
CT or perfusion CT, so direct comparison between these
advanced techniques and dual-phase CT in predicting clinical
outcome was not performed. Finally, our routine CT protocol was
not optimized to assess collateral status in patients with acute
ischemic stroke. According to a previous study using time-resolved
CTA [21], alteration of time delay from contrast injection to
image acquisition has the potential to impair outcome prediction.
Therefore, efforts to establish an appropriate CT protocol and
future studies with this optimized CT protocol in a larger scale are
required.
Conclusions
In conclusion, dual-phase CT is feasible for assessing collateral
status in patients with acute ischemic stroke, showing substantial
interobserver agreement. Collateral status on dual-phase CT can
also be a useful predictor for clinical outcome in acute stroke
patients subjected to IA treatment, especially when advanced CT
techniques are not available in emergency situations.
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